Weiss Multi Strategy Advisers LLC Astria Therapeutics, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$4.42 - $8.06 $130,217 - $237,455	29,461 Added 58.29%	80,000 $614,000
Q3 2023 Nov 14, 2023	SELL	$6.89 - $9.86 $1.2 Million - $1.71 Million	-173,706 Reduced 77.46%	50,539 $377,000
Q2 2023 Aug 14, 2023	BUY	$8.33 - $13.72 $148,748 - $244,998	17,857 Added 8.65%	224,245 $1.87 Million
Q1 2023 May 15, 2023	BUY	$11.2 - $15.79 $1.59 Million - $2.24 Million	141,820 Added 219.64%	206,388 $2.75 Million
Q4 2022 Feb 14, 2023	BUY	$7.44 - $14.89 $480,385 - $961,417	64,568 New	64,568 $961,000

107

48.6M

48K

9.3K

Ticker ATXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,178,000
Market Cap $146M
Description
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.